Arthritis News and Research

Latest Arthritis News and Research

Hanwha, Merck partner to develop and commercialize HD203

Hanwha, Merck partner to develop and commercialize HD203

HSS to host international Osteoarthritis Summit on June 17, 18

HSS to host international Osteoarthritis Summit on June 17, 18

NYU Langone webinar discusses advances in the treatment of RA

NYU Langone webinar discusses advances in the treatment of RA

HHS adds eight substances to 12th Report on Carcinogens

HHS adds eight substances to 12th Report on Carcinogens

Poplar bud extracts can serve as good source of antioxidants for skin creams

Poplar bud extracts can serve as good source of antioxidants for skin creams

State roundup: N.J. plan would cut Medicaid by $500 million

State roundup: N.J. plan would cut Medicaid by $500 million

Rosa, Profil Institute partner to offer simulation technology for diabetes and obesity clinical trials

Rosa, Profil Institute partner to offer simulation technology for diabetes and obesity clinical trials

Topline results from 4SC vidofludimus Phase IIb trial against rheumatoid arthritis

Topline results from 4SC vidofludimus Phase IIb trial against rheumatoid arthritis

Avoiding repetitive activities that increase stress on the joints may prevent bursitis

Avoiding repetitive activities that increase stress on the joints may prevent bursitis

Study explores link between hospital procedure volume, surgical outcomes after joint replacements

Study explores link between hospital procedure volume, surgical outcomes after joint replacements

Ligand's LGD-4033 Phase I clinical trial data presented at the Endocrine Society annual meeting

Ligand's LGD-4033 Phase I clinical trial data presented at the Endocrine Society annual meeting

Bayer HealthCare seeks EU marketing authorization of VEGF Trap-Eye for treatment of wet AMD

Bayer HealthCare seeks EU marketing authorization of VEGF Trap-Eye for treatment of wet AMD

Bristol-Myers Squibb's second YERVOY Phase 3 trial on metastatic melanoma meets primary endpoint

Bristol-Myers Squibb's second YERVOY Phase 3 trial on metastatic melanoma meets primary endpoint

Ross River Fever vaccine trials begin

Ross River Fever vaccine trials begin

Roche, Bristol-Myers Squibb to evaluate YERVOY and vemurafenib treatment for metastatic melanoma

Roche, Bristol-Myers Squibb to evaluate YERVOY and vemurafenib treatment for metastatic melanoma

New approach for identifying 'self' proteins targeted in autoimmune diseases

New approach for identifying 'self' proteins targeted in autoimmune diseases

McMaster, Abbott create new education chair to focus on rheumatology

McMaster, Abbott create new education chair to focus on rheumatology

Researchers discover new drug target that may effectively prevent onset of Huntington's disease

Researchers discover new drug target that may effectively prevent onset of Huntington's disease

SQI Diagnostics reports net loss of $1,874,000 for second quarter 2011

SQI Diagnostics reports net loss of $1,874,000 for second quarter 2011

HHS uses new devices to meet growing need of joint replacements among baby boomers

HHS uses new devices to meet growing need of joint replacements among baby boomers

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.